reports
Ford Equity US Rating and Forecast Report
Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of EndoChoice Holdings, Inc. (NYSE: GI) (“EndoChoice” or the “Company”) relating to the proposed buyout of EndoChoice by Boston Scientific Corporation. Under the terms of the agreement, EndoChoice shareholders are anticipated to receive $8.00 in cash for each share of EndoChoice commo...
ENDOCHOICE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willi...
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of EndoChoice Holdings, Inc. (“EndoChoice”) (NYSE: GI) concerning the acquisition by Boston Scientific Corporation. Under the terms of the agreement, valued at approximately $210 million, EndoChoice shareholders will only receive $8.00 per EndoChoice share owned. The consideration is significantly lower than at...
ENDOCHOICE HOLDINGS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. An...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of EndoChoice Holdings, Inc. (NYSE: GI)? Did you purchase any of your shares prior to September 27, 2016? Do you think the proposed buyout price is too low? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of EndoChoice Holdings, Inc. (“EndoChoice” or the “Company”) (NYSE: GI)...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.